Article Information
History
- December 2, 2019.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Manuel V. Borca1,*,
- Elizabeth Ramirez Medina1,2,
- Ediane Silva1,3,
- Elizabeth Vuono1,4,
- Ayushi Rai1,5,
- Sarah Pruitt1,5,
- Lauren G. Holinka1,
- Lauro Velazquez Salinas1,3,
- James Zhu1 and
- Douglas P. Gladue1,*
- 1Agricultural Research Service, U.S. Department of Agriculture, Plum Island Animal Disease Center, Greenport, NY 11944, USA
- 2Department of Pathobiology and Veterinary Science, University of Connecticut, Storrs, CT 06269, USA
- 3Department of Anatomy and Physiology, Kansas State University, Manhattan, KS 66506
- 4Department of Pathobiology and Population Medicine, Mississippi State University, P.O. Box 6100, MS 39762
- 5Oak Ridge Institute for Science and Education (ORISE), Oak Ridge, TN 37830, USA
- ↵*Corresponding authors: Plum Island Animal Disease Center, USDA/ARS/NAA, P.O. Box 848, Greenport, NY 11944-0848, USA, Fax: +1 631 323 3006 Phone: +1 631 323 3131, E-mail address: manuel.borca{at}ars.usda.gov, douglas.gladue{at}ars.usda.gov
Posted December 02, 2019.
Development of a highly effective African swine fever virus vaccine by deletion of the I177L gene results in sterile immunity against the current epidemic Eurasia strain
